Importantly, SLC39A1 was also validated as a novel independent prognostic biomarker for gastric adenocarcinoma (hazard ratio 1.732, 95% confident interval 1.041-2.881, P=0.035). Here, SLC39A1 is linked to gastric adenocarcinoma.